IMMUNOHISTOCHEMICAL EXPRESSION OF CANCER STEM CELL MARKER (ALDH1) IN A PROSTATE CANCER

Journal Title: European Journal of Pharmaceutical and Medical Research - Year 2019, Vol 6, Issue 1

Abstract

Background: Cancer stem cells were identified in several cancers, including PCa, and have been proposed to explain the metastatic capacity, recurrence, and resistance to hormone, radio and chemotherapy in established cell lines from PCa origin, particularly from metastasis. Enzymatic assays and immunohistochemistry have identified several proteins and surface markers that are expressed by CSCs and may be used to identify them in patients. Aim of the study: To assess the immunohistochemical (IHC) expression patterns of the ALDHmarker in PCa, BPH and in apparently normal looking prostate tissue. Methods: A cross-sectional Study carried out at department of histopathology and forensic medicine at Al-Mustansirya medical college and teaching lab of Al-Yarmook Teaching Hospital during a period of one year from (1st of august 2017 to 30th of July 2018). It involved 90 specimens; and these specimens were divided into the following: 60 of them were collected retrospectively depending on the archived files of patients diagnosed either with BPH (30 specimens) or with PCa (30 specimens) in the years 2016 and 2017 in Al-Yarmook Teaching Hospital and in the private labs. The other 30 specimens of normal prostatic tissue were collected prospectively from autopsy presented in forensic medicine directorate during the first three months of 2018. All patients diagnosed with BPH or PCa during 2016 and 2017 were included without any exclusion. Positive control: Human gallbladder tissue for ALDH marker with each run. Results: The mean age of the patients was 73.71 ± 8.15 years. The highest proportion of specimens of PCa (Group A) was graded ≤ 7 by Gleason Grading System (53.3%). There were significant associations (P < 0.05) between all these CSC marker results and prevalence of PCa. Positive ALDH marker result was significantly associated (P=0.024) with high Gleason Grading System. Conclusion: ALDH1 is significantly expressed in prostate carcinomas, and more likely so in cases with Gleason grading system 8.

Authors and Affiliations

Hadeel Ismail Mohsen

Keywords

Related Articles

EWING’S SARCOMA OF THE MAXILLARY SINUS IN A CHILD: A CASE REPORT AND REVIEW OF LITTERATURE

Ewing’s sarcoma is typically an aggressive, poorly differentiated tumor affecting children and young adults, it accounts for 4–6% of all primary bone tumors and facial primary localizations occur in only 1–4% of all case...

A BRIEF PREFACE ON STUDIES ON GENE TRAPPING

Every species has its own expression of genome; even though it has common alphabets the expression is different from species to species and genus to genus. During the evolution of species the genes get modified to reach...

TRAJECTORY OF HYPERTENSION IN AFRICA FROM NEAR ABSENCE TO A SILENT EMERGING EPIDEMIC

ALTHOUGH HYPERTENSION WAS VIRTUALLY ABSENT IN AFRICA BEFORE 1930 IT HAS NOW BECOME AN emerging epidemic essentially responsible for the double burden of disease in developing countries. This non-communicable disease (NCD...

NEUROCYSTICERCOSIS AS A PRESENTING FEATURE OF PICA: A CASE REPORT

Neurocysticercosis (NCC) is a zoonotic disease caused by the larval form of the cestode Taenia solium. It is the commonest parasitic infection of the Central nervous system. NCC has a worldwide distribution and is mainly...

AGE RELATED MACULAR DEGENARATION

Age-related macular degeneration (AMD) is a disease of the retina that usually develops in people aged 60 years and older. It affects about 8.7% of the world’s population and is the leading cause of blindness among peopl...

Download PDF file
  • EP ID EP672476
  • DOI -
  • Views 142
  • Downloads 0

How To Cite

Hadeel Ismail Mohsen (2019). IMMUNOHISTOCHEMICAL EXPRESSION OF CANCER STEM CELL MARKER (ALDH1) IN A PROSTATE CANCER. European Journal of Pharmaceutical and Medical Research, 6(1), 89-95. https://europub.co.uk/articles/-A-672476